Comerica Securities’s Exelixis EXEL Stock Holding History

Comerica Securities’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12	Closed	-$192	–	774
2022 Q4	$192	Buy	+12	New	+$196	﹤0.01%	1487

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Comerica Securities's EXEL Position: Q1 2023 in Review

Comerica Securities sold out of Exelixis (EXEL) in Q1 2023, closing a stake of 12 shares — an estimated $192 sold.

Comerica Securities first reported a position in EXEL in Q4 2022 and held it in 1 quarter. The position peaked at $192 in Q4 2022. 363 funds tracked by Wall St. Rank hold EXEL as of Q1 2023.

Comerica Securities reported no remaining Exelixis position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 12 Exelixis shares in Q1 2023, an estimated $192.
Comerica Securities first reported a position in Exelixis in Q4 2022 and held it in 1 quarter.
Comerica Securities's Exelixis position peaked at $192 in Q4 2022.
363 funds tracked by Wall St. Rank held Exelixis as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.